Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis

키워드

참고문헌 (24)

1. Tandon P, "Sarcopenia and frailty in decompensated cirrhosis", J Hepatol (2021)
2. Jimin Han, "Prognostic implications of trunk muscle mass in liver cirrhosis", Clinical and Molecular Hepatology, 24(3), pp.297~298 (2018), 대한간학회
3. Sooyeon Oh, "Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma", Clinical and Molecular Hepatology, 26(4), pp.476~479 (2020), 대한간학회
4. Kanghyug Choi, "The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma", Clinical and Molecular Hepatology, 26(4), pp.492~505 (2020), 대한간학회[DOI]
5. Yoshiji H, "Evidence-based clinical practice guidelines for liver cirrhosis 2020", Hepatol Res, 51, pp.725~749 (2021)
6. Ji Won Han, "Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis", Clinical and Molecular Hepatology, 28(2), pp.219~231 (2022), 대한간학회[DOI]
7. Koya S, "Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease", Hepatol Res, 47, pp.E22~E34 (2017)
8. Shiraki M, "Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis", Nutrition, 26, pp.269~275 (2010)
9. Phillips T, "Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction", FASEB J, 19, pp.668~670 (2005)
10. Li J, "TNF receptorassociated factor 6 mediates TNFα-induced skeletal muscle atrophy in mice during aging", J Bone Miner Res, 35, pp.1535~1548 (2020)
11. Nishimura N, "Intestinal permeability is a mechanical rheostat in the pathogenesis of liver cirrhosis", Int J Mol Sci, 22, pp.6921~ (2021)
12. Chopyk DM, "Contribution of the intestinal microbiome and gut barrier to hepatic disorders", Gastroenterology, 159, pp.849~863 (2020)
13. Plaza-Díaz J, "The gut barrier, intestinal microbiota, and liver disease : molecular mechanisms and strategies to manage", Int J Mol Sci, 21, pp.8351~ (2020)
14. Kawaguchi T, "Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis", Hepatology, 31, pp.1285~1295 (2000)
15. Zhao TY, "IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats", BMC Gastroenterol, 15, pp.77~ (2015)
16. Assimakopoulos SF, "Altered intestinal tight junctions’ expression in patients with liver cirrhosis : a pathogenetic mechanism of intestinal hyperpermeability", Eur J Clin Invest, 42, pp.439~446 (2012)
17. Ankur Jindal, "Sarcopenia: Ammonia metabolism and hepatic encephalopathy", Clinical and Molecular Hepatology, 25(3), pp.270~279 (2019), 대한간학회
18. Kawaguchi T, "Rifaximin-altered gut microbiota components associated with liver", neuropsychological functions in patients with hepatic encephalopathy : an exploratory data analysis of phase II, Hepatol Res, pp.2019, 49[DOI]
19. Bajaj JS, "Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy", PLoS One, 8, pp.e60042~ (2013)
20. Trebicka J, "The microbiota in cirrhosis and its role in hepatic decompensation", J Hepatol (2021)
21. Kumar A, "Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis", Hepatology, 65, pp.2045~2058 (2017)
22. Fujinaga Y, "Effective combination therapy of angiotensin-II receptor blocker and rifaximin for hepatic fibrosis in rat model of nonalcoholic steatohepatitis", Int J Mol Sci, 21, pp.5589~ (2020)
23. Kaji K, "Rifaximin alleviates endotoxemia with decreased serum levels of soluble CD163 and mannose receptor and partial modification of gut microbiota in cirrhotic patients", Antibiotics(Basel), 9, pp.145~ (2020)
24. Gao J, "The association of fried meat consumption with the gut microbiota and fecal metabolites and its impact on glucose homoeostasis, intestinal endotoxin levels, and systemic inflammation : a randomized controlled-feeding trial", Diabetes Care, 44, pp.1970~1979 (2021)

관련 논문AI추천